A homology model of the ADAMTS7 metalloproteinase domain was created.
Structural comparisons of ADAMTS binding sites indicate selective binding regions.
We propose a pharmacophore for ADAMTS7.
Pharmacophore should facilitate development of a new therapeutic target for CAD.